{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:58:23Z","timestamp":1778029103408,"version":"3.51.4"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/74881\/2010"],"award-info":[{"award-number":["SFRH\/BD\/74881\/2010"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s40478-016-0310-y","type":"journal-article","created":{"date-parts":[[2016,4,22]],"date-time":"2016-04-22T01:13:43Z","timestamp":1461287623000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":156,"title":["Fasudil attenuates aggregation of \u03b1-synuclein in models of Parkinson\u2019s disease"],"prefix":"10.1186","volume":"4","author":[{"given":"Lars","family":"Tatenhorst","sequence":"first","affiliation":[]},{"given":"Katrin","family":"Eckermann","sequence":"additional","affiliation":[]},{"given":"Vivian","family":"Dambeck","sequence":"additional","affiliation":[]},{"given":"Luis","family":"Fonseca-Ornelas","sequence":"additional","affiliation":[]},{"given":"Hagen","family":"Walle","sequence":"additional","affiliation":[]},{"given":"Tom\u00e1s","family":"Lopes da Fonseca","sequence":"additional","affiliation":[]},{"given":"Jan C.","family":"Koch","sequence":"additional","affiliation":[]},{"given":"Stefan","family":"Becker","sequence":"additional","affiliation":[]},{"given":"Lars","family":"T\u00f6nges","sequence":"additional","affiliation":[]},{"given":"Mathias","family":"B\u00e4hr","sequence":"additional","affiliation":[]},{"given":"Tiago F.","family":"Outeiro","sequence":"additional","affiliation":[]},{"given":"Markus","family":"Zweckstetter","sequence":"additional","affiliation":[]},{"given":"Paul","family":"Lingor","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2016,4,22]]},"reference":[{"key":"310_CR1","doi-asserted-by":"crossref","first-page":"9193","DOI":"10.1074\/jbc.M111.325548","volume":"287","author":"B Ahmad","year":"2012","unstructured":"Ahmad B, Lapidus LJ. Curcumin prevents aggregation in \u03b1-synuclein by increasing reconfiguration rate. J Biol Chem. 2012;287:9193\u20139. doi: 10.1074\/jbc.M111.325548 .","journal-title":"J Biol Chem"},{"key":"310_CR2","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/513481a","volume":"513","author":"J Baell","year":"2014","unstructured":"Baell J, Walters MA. Chemistry: Chemical con artists foil drug discovery. Nature. 2014;513:481\u20133. doi: 10.1038\/513481a .","journal-title":"Nature"},{"key":"310_CR3","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/srep00809","volume":"2","author":"C Barcia","year":"2012","unstructured":"Barcia C, Ros CM, Annese V, Carrillo-de Sauvage MA, Ros-Bernal F, G\u00f3mez A, et al. ROCK\/Cdc42-mediated microglial motility and gliapse formation lead to phagocytosis of degenerating dopaminergic neurons in vivo. Sci Rep. 2012;2:809. doi: 10.1038\/srep00809 .","journal-title":"Sci Rep"},{"key":"310_CR4","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.neuron.2013.09.004","volume":"79","author":"JT Bendor","year":"2013","unstructured":"Bendor JT, Logan TP, Edwards RH. The function of \u03b1-synuclein. Neuron. 2013;79:1044\u201366. doi: 10.1016\/j.neuron.2013.09.004 .","journal-title":"Neuron"},{"key":"310_CR5","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jns.2011.06.054","volume":"310","author":"J Benito-Le\u00f3n","year":"2011","unstructured":"Benito-Le\u00f3n J, Louis ED, Posada IJ, S\u00e1nchez-Ferro \u00c1, Trincado R, Villarejo A, et al. Population-based case-control study of cognitive function in early Parkinson\u2019s disease (NEDICES). J Neurol Sci. 2011;310:176\u201382. doi: 10.1016\/j.jns.2011.06.054 .","journal-title":"J Neurol Sci"},{"key":"310_CR6","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/nprot.2006.205","volume":"1","author":"RA Bevins","year":"2006","unstructured":"Bevins RA, Besheer J. Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study \u201crecognition memory\u201d. Nat Protoc. 2006;1:1306\u201311. doi: 10.1038\/nprot.2006.205 .","journal-title":"Nat Protoc"},{"key":"310_CR7","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1515\/BC.2007.061","volume":"388","author":"O Boehm","year":"2007","unstructured":"Boehm O, Zur B, Koch A, Tran N, Freyenhagen R, Hartmann M, et al. Clinical chemistry reference database for Wistar rats and C57\/BL6 mice. Biol Chem. 2007;388:547\u201354. doi: 10.1515\/BC.2007.061 .","journal-title":"Biol Chem"},{"key":"310_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2014.05.021","volume":"85","author":"A Borrajo","year":"2014","unstructured":"Borrajo A, Rodriguez-Perez AI, Villar-Cheda B, Guerra MJ, Labandeira-Garcia JL. Inhibition of the microglial response is essential for the neuroprotective effects of Rho-Kinase inhibitors on MPTP-induced dopaminergic cell death. Neuropharmacology. 2014;85:1\u20138. doi: 10.1016\/j.neuropharm.2014.05.021 .","journal-title":"Neuropharmacology"},{"key":"310_CR9","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1093\/oxfordjournals.humrep.a137958","volume":"8","author":"KH Cui","year":"1993","unstructured":"Cui KH, Pannall P, Cates G, Matthews CD. Blood analysis of mice born following single-cell embryo biopsy. Hum Reprod. 1993;8:1906\u20139.","journal-title":"Hum Reprod"},{"key":"310_CR10","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/mds.23443","volume":"26","author":"TO Dalaker","year":"2011","unstructured":"Dalaker TO, Zivadinov R, Ramasamy DP, Beyer MK, Alves G, Bronnick KS, et al. Ventricular enlargement and mild cognitive impairment in early Parkinson\u2019s disease. Mov Disord. 2011;26:297\u2013301. doi: 10.1002\/mds.23443 .","journal-title":"Mov Disord"},{"key":"310_CR11","volume-title":"The Laboratory Mouse","author":"PJ Danneman","year":"2013","unstructured":"Danneman PJ, Suckow MA, Brayton CF. The Laboratory Mouse. 2nd ed. Boca Raton: CRC Press Taylor & Francis Group; 2013.","edition":"2"},{"key":"310_CR12","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1212\/01.wnl.0000247740.47667.03","volume":"68","author":"ER Dorsey","year":"2007","unstructured":"Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology. 2007;68:384\u20136. doi: 10.1212\/01.wnl.0000247740.47667.03 .","journal-title":"Neurology"},{"key":"310_CR13","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nsmb.1437","volume":"15","author":"DE Ehrnhoefer","year":"2008","unstructured":"Ehrnhoefer DE, Bieschke J, Boeddrich A, Herbst M, Masino L, Lurz R, et al. EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers. Nat Struct Mol Biol. 2008;15:558\u201366. doi: 10.1038\/nsmb.1437 .","journal-title":"Nat Struct Mol Biol"},{"key":"310_CR14","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3390\/biom5020435","volume":"5","author":"TL Fonseca da","year":"2015","unstructured":"da Fonseca TL, Villar-Piqu\u00e9 A, Outeiro TF. The Interplay between Alpha-Synuclein Clearance and Spreading. Biomolecules. 2015;5:435\u201371. doi: 10.3390\/biom5020435 .","journal-title":"Biomolecules"},{"key":"310_CR15","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1523\/JNEUROSCI.2336-15.2016","volume":"36","author":"EG Gentry","year":"2016","unstructured":"Gentry EG, Henderson BW, Arrant AE, Gearing M, Feng Y, Riddle NC, et al. Rho kinase inhibition as a therapeutic for progressive supranuclear palsy and corticobasal degeneration. J Neurosci. 2016;36:1316\u201323. doi: 10.1523\/JNEUROSCI.2336-15.2016 .","journal-title":"J Neurosci"},{"key":"310_CR16","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0896-6273(02)00682-7","volume":"34","author":"BI Giasson","year":"2002","unstructured":"Giasson BI, Duda JE, Quinn SM, Zhang B, Trojanowski JQ, Lee VM-Y. Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein. Neuron. 2002;34:521\u201333.","journal-title":"Neuron"},{"key":"310_CR17","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S1044-7431(03)00198-2","volume":"24","author":"S Gispert","year":"2003","unstructured":"Gispert S, Del Turco D, Garrett L, Chen A, Bernard DJ, Hamm-Clement J, et al. Transgenic mice expressing mutant A53T human alpha-synuclein show neuronal dysfunction in the absence of aggregate formation. Mol Cell Neurosci. 2003;24:419\u201329.","journal-title":"Mol Cell Neurosci"},{"key":"310_CR18","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0197-4580(02)00091-X","volume":"24","author":"T Gomez-Isla","year":"2003","unstructured":"Gomez-Isla T, Irizarry MC, Mariash A, Cheung B, Soto O, Schrump S, et al. Motor dysfunction and gliosis with preserved dopaminergic markers in human alpha-synuclein A30P transgenic mice. Neurobiol Aging. 2003;24:245\u201358.","journal-title":"Neurobiol Aging"},{"key":"310_CR19","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1002\/jnr.22331","volume":"88","author":"DR Graham","year":"2010","unstructured":"Graham DR, Sidhu A. Mice expressing the A53T mutant form of human alpha-synuclein exhibit hyperactivity and reduced anxiety-like behavior. J Neurosci Res. 2010;88:1777\u201383. doi: 10.1002\/jnr.22331 .","journal-title":"J Neurosci Res"},{"key":"310_CR20","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.bbr.2014.10.025","volume":"285","author":"B Grayson","year":"2015","unstructured":"Grayson B, Leger M, Piercy C, Adamson L, Harte M, Neill JC. Assessment of disease-related cognitive impairments using the novel object recognition (NOR) task in rodents. Behav Brain Res. 2015;285:176\u201393. doi: 10.1016\/j.bbr.2014.10.025 .","journal-title":"Behav Brain Res"},{"key":"310_CR21","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/mds.25857","volume":"29","author":"GM Halliday","year":"2014","unstructured":"Halliday GM, Leverenz JB, Schneider JS, Adler CH. The neurobiological basis of cognitive impairment in Parkinson\u2019s disease. Mov Disord. 2014;29:634\u201350. doi: 10.1002\/mds.25857 .","journal-title":"Mov Disord"},{"key":"310_CR22","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0022-2836(02)00775-1","volume":"322","author":"W Hoyer","year":"2002","unstructured":"Hoyer W, Antony T, Cherny D, Heim G, Jovin TM, Subramaniam V. Dependence of alpha-synuclein aggregate morphology on solution conditions. J Mol Biol. 2002;322:383\u201393.","journal-title":"J Mol Biol"},{"key":"310_CR23","doi-asserted-by":"crossref","first-page":"16233","DOI":"10.1021\/bi048453u","volume":"43","author":"W Hoyer","year":"2004","unstructured":"Hoyer W, Cherny D, Subramaniam V, Jovin TM. Impact of the acidic C-terminal region comprising amino acids 109-140 on alpha-synuclein aggregation in vitro. Biochemistry. 2004;43:16233\u201342. doi: 10.1021\/bi048453u .","journal-title":"Biochemistry"},{"issue":"33\u20138","key":"310_CR24","first-page":"27","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey W, Dalke A, Schulten K. VMD: visual molecular dynamics. J Mol Graph. 1996;14(33\u20138):27\u20138.","journal-title":"J Mol Graph"},{"key":"310_CR25","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/brb3.86","volume":"2","author":"Y Izawa","year":"2012","unstructured":"Izawa Y, Tateno H, Kameda H, Hirakawa K, Hato K, Yagi H, et al. Role of C-terminal negative charges and tyrosine residues in fibril formation of \u03b1-synuclein. Brain Behav. 2012;2:595\u2013605. doi: 10.1002\/brb3.86 .","journal-title":"Brain Behav"},{"key":"310_CR26","doi-asserted-by":"crossref","first-page":"e1225","DOI":"10.1038\/cddis.2014.191","volume":"5","author":"JC Koch","year":"2014","unstructured":"Koch JC, T\u00f6nges L, Barski E, Michel U, B\u00e4hr M, Lingor P. ROCK2 is a major regulator of axonal degeneration, neuronal death and axonal regeneration in the CNS. Cell Death Dis. 2014;5:e1225. doi: 10.1038\/cddis.2014.191 .","journal-title":"Cell Death Dis"},{"key":"310_CR27","first-page":"273","volume":"8","author":"JC Koch","year":"2014","unstructured":"Koch JC, T\u00f6nges L, Michel U, B\u00e4hr M, Lingor P. Viral vector-mediated downregulation of RhoA increases survival and axonal regeneration of retinal ganglion cells. Front Cell Neurosci. 2014;8:273. doi: 10.3389\/fncel.2014.00273 .","journal-title":"Front Cell Neurosci"},{"key":"310_CR28","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0298-106","volume":"18","author":"R Kr\u00fcger","year":"1998","unstructured":"Kr\u00fcger R, Kuhn W, M\u00fcller T, Woitalla D, Graeber M, K\u00f6sel S, et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson\u2019s disease. Nat Genet. 1998;18:106\u20138. doi: 10.1038\/ng0298-106 .","journal-title":"Nat Genet"},{"key":"310_CR29","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrn3406","volume":"14","author":"H a Lashuel","year":"2013","unstructured":"Lashuel H a, Overk CR, Oueslati A, Masliah E. The many faces of \u03b1-synuclein: from structure and toxicity to therapeutic target. Nat Rev Neurosci. 2013;14:38\u201348. doi: 10.1038\/nrn3406 .","journal-title":"Nat Rev Neurosci"},{"key":"310_CR30","doi-asserted-by":"crossref","first-page":"e1004741","DOI":"10.1371\/journal.pgen.1004741","volume":"10","author":"DF L\u00e1zaro","year":"2014","unstructured":"L\u00e1zaro DF, Rodrigues EF, Langohr R, Shahpasandzadeh H, Ribeiro T, Guerreiro P, et al. Systematic comparison of the effects of alpha-synuclein mutations on its oligomerization and aggregation. PLoS Genet. 2014;10:e1004741. doi: 10.1371\/journal.pgen.1004741 .","journal-title":"PLoS Genet"},{"key":"310_CR31","doi-asserted-by":"crossref","first-page":"8968","DOI":"10.1073\/pnas.132197599","volume":"99","author":"MK Lee","year":"2002","unstructured":"Lee MK, Stirling W, Xu Y, Xu X, Qui D, Mandir AS, et al. Human a-synuclein-harboring familial Parkinson\u2019 s disease-linked Ala-53 3 Thr mutation causes neurodegenerative disease with a-synuclein aggregation in transgenic mice. Proc Natl Acad Sci U S A. 2002;99:8968\u201373.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"310_CR32","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jmb.2011.05.046","volume":"411","author":"K Levitan","year":"2011","unstructured":"Levitan K, Chereau D, Cohen SIA, Knowles TPJ, Dobson CM, Fink AL, et al. Conserved C-terminal charge exerts a profound influence on the aggregation rate of \u03b1-synuclein. J Mol Biol. 2011;411:329\u201333. doi: 10.1016\/j.jmb.2011.05.046 .","journal-title":"J Mol Biol"},{"issue":"Pt 1","key":"310_CR33","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1093\/brain\/123.10.2077","volume":"123","author":"GN Lewis","year":"2000","unstructured":"Lewis GN, Byblow WD, Walt SE. Stride length regulation in Parkinson\u2019s disease: the use of extrinsic, visual cues. Brain. 2000;123(Pt 1):2077\u201390.","journal-title":"Brain"},{"key":"310_CR34","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.nbd.2009.06.011","volume":"36","author":"M Li","year":"2009","unstructured":"Li M, Huang Y, Ma AAK, Lin E, Diamond MI. Y-27632 improves rotarod performance and reduces huntingtin levels in R6\/2 mice. Neurobiol Dis. 2009;36:413\u201320. doi: 10.1016\/j.nbd.2009.06.011 .","journal-title":"Neurobiol Dis"},{"key":"310_CR35","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1073\/pnas.0406976102","volume":"102","author":"W Li","year":"2005","unstructured":"Li W, West N, Colla E, Pletnikova O, Troncoso JC, Marsh L, et al. Aggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson\u2019s disease-linked mutations. Proc Natl Acad Sci U S A. 2005;102:2162\u20137. doi: 10.1073\/pnas.0406976102 .","journal-title":"Proc Natl Acad Sci U S A"},{"key":"310_CR36","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.neuron.2005.05.002","volume":"46","author":"JE Lisman","year":"2005","unstructured":"Lisman JE, Grace AA. The hippocampal-VTA loop: controlling the entry of information into long-term memory. Neuron. 2005;46:703\u201313. doi: 10.1016\/j.neuron.2005.05.002 .","journal-title":"Neuron"},{"key":"310_CR37","doi-asserted-by":"crossref","first-page":"22670","DOI":"10.1074\/jbc.M501508200","volume":"280","author":"C-W Liu","year":"2005","unstructured":"Liu C-W, Giasson BI, Lewis KA, Lee VM, Demartino GN, Thomas PJ. A precipitating role for truncated alpha-synuclein and the proteasome in alpha-synuclein aggregation: implications for pathogenesis of Parkinson disease. J Biol Chem. 2005;280:22670\u20138. doi: 10.1074\/jbc.M501508200 .","journal-title":"J Biol Chem"},{"key":"310_CR38","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.nbd.2011.12.038","volume":"48","author":"K L\u00f6w","year":"2012","unstructured":"L\u00f6w K, Aebischer P. Use of viral vectors to create animal models for Parkinson\u2019s disease. Neurobiol Dis. 2012;48:189\u2013201. doi: 10.1016\/j.nbd.2011.12.038 .","journal-title":"Neurobiol Dis"},{"key":"310_CR39","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00213-011-2536-5","volume":"220","author":"L Lyon","year":"2012","unstructured":"Lyon L, Saksida LM, Bussey TJ. Spontaneous object recognition and its relevance to schizophrenia: a review of findings from pharmacological, genetic, lesion and developmental rodent models. Psychopharmacology (Berl). 2012;220:647\u201372. doi: 10.1007\/s00213-011-2536-5 .","journal-title":"Psychopharmacology (Berl)"},{"key":"310_CR40","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/j.1460-9568.2012.08012.x","volume":"35","author":"I Magen","year":"2012","unstructured":"Magen I, Fleming SM, Zhu C, Garcia EC, Cardiff KM, Dinh D, et al. Cognitive deficits in a mouse model of pre-manifest Parkinson\u2019s disease. Eur J Neurosci. 2012;35:870\u201382. doi: 10.1111\/j.1460-9568.2012.08012.x .","journal-title":"Eur J Neurosci"},{"key":"310_CR41","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1523\/JNEUROSCI.08-08-02804.1988","volume":"8","author":"L Maroteaux","year":"1988","unstructured":"Maroteaux L, Campanelli JT, Scheller RH. Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J Neurosci. 1988;8:2804\u201315.","journal-title":"J Neurosci"},{"key":"310_CR42","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0306-4522(01)00113-0","volume":"104","author":"PJ McLean","year":"2001","unstructured":"McLean PJ, Kawamata H, Hyman BT. Alpha-synuclein-enhanced green fluorescent protein fusion proteins form proteasome sensitive inclusions in primary neurons. Neuroscience. 2001;104:901\u201312.","journal-title":"Neuroscience"},{"key":"310_CR43","doi-asserted-by":"crossref","first-page":"27582","DOI":"10.1074\/jbc.M114.636027","volume":"290","author":"B Moree","year":"2015","unstructured":"Moree B, Yin G, L\u00e1zaro DF, Munari F, Stroh\u00e4ker T, Giller K, et al. Small molecules detected by second-harmonic generation modulate the conformation of monomeric \u03b1-synuclein and reduce its aggregation in cells. J Biol Chem. 2015;290:27582\u201393. doi: 10.1074\/jbc.M114.636027 .","journal-title":"J Biol Chem"},{"key":"310_CR44","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrd1719","volume":"4","author":"BK Mueller","year":"2005","unstructured":"Mueller BK, Mack H, Teusch N. Rho kinase, a promising drug target for neurological disorders. Nat Rev Drug Discov. 2005;4:387\u201398. doi: 10.1038\/nrd1719 .","journal-title":"Nat Rev Drug Discov"},{"key":"310_CR45","doi-asserted-by":"crossref","first-page":"e70274","DOI":"10.1371\/journal.pone.0070274","volume":"8","author":"KL Paumier","year":"2013","unstructured":"Paumier KL, Sukoff Rizzo SJ, Berger Z, Chen Y, Gonzales C, Kaftan E, et al. Behavioral characterization of A53T mice reveals early and late stage deficits related to Parkinson\u2019s disease. PLoS One. 2013;8:e70274. doi: 10.1371\/journal.pone.0070274 .","journal-title":"PLoS One"},{"key":"310_CR46","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1021\/jp508971m","volume":"119","author":"S Piana","year":"2015","unstructured":"Piana S, Donchev AG, Robustelli P, Shaw DE. Water dispersion interactions strongly influence simulated structural properties of disordered protein States. J Phys Chem B. 2015;119:5113\u201323. doi: 10.1021\/jp508971m .","journal-title":"J Phys Chem B"},{"key":"310_CR47","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease. Science. 1997;276:2045\u20137.","journal-title":"Science"},{"key":"310_CR48","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/mds.24996","volume":"27","author":"RB Postuma","year":"2012","unstructured":"Postuma RB, Aarsland D, Barone P, Burn DJ, Hawkes CH, Oertel W, et al. Identifying prodromal Parkinson\u2019s disease: pre-motor disorders in Parkinson\u2019s disease. Mov Disord. 2012;27:617\u201326. doi: 10.1002\/mds.24996 .","journal-title":"Mov Disord"},{"key":"310_CR49","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3181\/00379727-78-19210","volume":"78","author":"ES Russel","year":"1951","unstructured":"Russel ES, Neufeld EF, Higgins CT. Comparison of normal blood picture of young adults from 18 inbred strains of mice. Proc Soc Exp Biol Med. 1951;78:761\u20136.","journal-title":"Proc Soc Exp Biol Med"},{"key":"310_CR50","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.nbd.2014.09.013","volume":"73","author":"K-A Saal","year":"2015","unstructured":"Saal K-A, Koch JC, Tatenhorst L, Szeg\u0151 EM, Ribas VT, Michel U, et al. AAV.shRNA-mediated downregulation of ROCK2 attenuates degeneration of dopaminergic neurons in toxin-induced models of Parkinson\u2019s disease in vitro and in vivo. Neurobiol Dis. 2015;73:150\u201362. doi: 10.1016\/j.nbd.2014.09.013 .","journal-title":"Neurobiol Dis"},{"key":"310_CR51","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1523\/JNEUROSCI.3463-05.2006","volume":"26","author":"BH Schott","year":"2006","unstructured":"Schott BH, Seidenbecher CI, Fenker DB, Lauer CJ, Bunzeck N, Bernstein H-G, et al. The dopaminergic midbrain participates in human episodic memory formation: evidence from genetic imaging. J Neurosci. 2006;26:1407\u201317. doi: 10.1523\/JNEUROSCI.3463-05.2006 .","journal-title":"J Neurosci"},{"key":"310_CR52","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","volume":"302","author":"AB Singleton","year":"2003","unstructured":"Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, et al. Alpha-Synuclein locus triplication causes Parkinson\u2019s disease. Science. 2003;302:841. doi: 10.1126\/science.1090278 .","journal-title":"Science"},{"key":"310_CR53","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. Alpha-synuclein in Lewy bodies. Nature. 1997;388:839\u201340. doi: 10.1038\/42166 .","journal-title":"Nature"},{"key":"310_CR54","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/jnnp.70.3.289","volume":"70","author":"H Stolze","year":"2001","unstructured":"Stolze H, Kuhtz-Buschbeck JP, Dr\u00fccke H, J\u00f6hnk K, Illert M, Deuschl G. Comparative analysis of the gait disorder of normal pressure hydrocephalus and Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 2001;70:289\u201397.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"310_CR55","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1242\/dmm.004267","volume":"3","author":"LJ Su","year":"2010","unstructured":"Su LJ, Auluck PK, Outeiro TF, Yeger-Lotem E, Kritzer JA, Tardiff DF, et al. Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson\u2019s disease models. Dis Model Mech. 2010;3:194\u2013208. doi: 10.1242\/dmm.004267 .","journal-title":"Dis Model Mech"},{"key":"310_CR56","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s11307-013-0695-y","volume":"16","author":"J Taniguchi","year":"2014","unstructured":"Taniguchi J, Seki C, Takuwa H, Kawaguchi H, Ikoma Y, Fujinaga M, et al. Evaluation of Rho-kinase activity in mice brain using N-[11C]methyl-hydroxyfasudil with positron emission tomography. Mol Imaging Biol. 2014;16:395\u2013402. doi: 10.1007\/s11307-013-0695-y .","journal-title":"Mol Imaging Biol"},{"key":"310_CR57","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1074\/jbc.M111.308668","volume":"287","author":"DF Tardiff","year":"2012","unstructured":"Tardiff DF, Tucci ML, Caldwell KA, Caldwell GA, Lindquist S. Different 8-hydroxyquinolines protect models of TDP-43 protein, \u03b1-synuclein, and polyglutamine proteotoxicity through distinct mechanisms. J Biol Chem. 2012;287:4107\u201320. doi: 10.1074\/jbc.M111.308668 .","journal-title":"J Biol Chem"},{"key":"310_CR58","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1097\/NEN.0000000000000095","volume":"73","author":"L Tatenhorst","year":"2014","unstructured":"Tatenhorst L, T\u00f6nges L, Saal K-A, Koch JC, Szeg\u0151 EM, B\u00e4hr M, et al. Rho kinase inhibition by Fasudil in the striatal 6-hydroxydopamine lesion mouse model of Parkinson disease. J Neuropathol Exp Neurol. 2014;73:770\u20139. doi: 10.1097\/NEN.0000000000000095 .","journal-title":"J Neuropathol Exp Neurol"},{"key":"310_CR59","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1093\/brain\/aws254","volume":"135","author":"L T\u00f6nges","year":"2012","unstructured":"T\u00f6nges L, Frank T, Tatenhorst L, Saal KA, Koch JC, Szego \u00c9M, et al. Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson\u2019s disease. Brain. 2012;135:3355\u201370. doi: 10.1093\/brain\/aws254 .","journal-title":"Brain"},{"key":"310_CR60","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/glia.22601","volume":"62","author":"L T\u00f6nges","year":"2014","unstructured":"T\u00f6nges L, G\u00fcnther R, Suhr M, Jansen J, Balck A, Saal K-A, et al. Rho kinase inhibition modulates microglia activation and improves survival in a model of amyotrophic lateral sclerosis. Glia. 2014;62:217\u201332. doi: 10.1002\/glia.22601 .","journal-title":"Glia"},{"key":"310_CR61","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3389\/fnmol.2011.00039","volume":"4","author":"L T\u00f6nges","year":"2011","unstructured":"T\u00f6nges L, Koch J-C, B\u00e4hr M, Lingor P. ROCKing regeneration: Rho kinase inhibition as molecular target for neurorestoration. Front Mol Neurosci. 2011;4:39. doi: 10.3389\/fnmol.2011.00039 .","journal-title":"Front Mol Neurosci"},{"key":"310_CR62","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1471-2202-11-92","volume":"11","author":"C Vandeputte","year":"2010","unstructured":"Vandeputte C, Taymans J-M, Casteels C, Coun F, Ni Y, Van Laere K, et al. Automated quantitative gait analysis in animal models of movement disorders. BMC Neurosci. 2010;11:92. doi: 10.1186\/1471-2202-11-92 .","journal-title":"BMC Neurosci"},{"key":"310_CR63","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.nbd.2012.04.010","volume":"47","author":"B Villar-Cheda","year":"2012","unstructured":"Villar-Cheda B, Dominguez-Meijide A, Joglar B, Rodriguez-Perez AI, Guerra MJ, Labandeira-Garcia JL. Involvement of microglial RhoA\/Rho-kinase pathway activation in the dopaminergic neuron death. Role of angiotensin via angiotensin type 1 receptors. Neurobiol Dis. 2012;47:268\u201379. doi: 10.1016\/j.nbd.2012.04.010 .","journal-title":"Neurobiol Dis"},{"key":"310_CR64","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/prot.20449","volume":"59","author":"WF Vranken","year":"2005","unstructured":"Vranken WF, Boucher W, Stevens TJ, Fogh RH, Pajon A, Llinas M, et al. The CCPN data model for NMR spectroscopy: development of a software pipeline. Proteins. 2005;59:687\u201396. doi: 10.1002\/prot.20449 .","journal-title":"Proteins"},{"key":"310_CR65","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00401-013-1114-9","volume":"125","author":"J Wagner","year":"2013","unstructured":"Wagner J, Ryazanov S, Leonov A, Levin J, Shi S, Schmidt F, et al. Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson\u2019s disease. Acta Neuropathol. 2013;125:795\u2013813. doi: 10.1007\/s00401-013-1114-9 .","journal-title":"Acta Neuropathol"},{"key":"310_CR66","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3233\/JPD-130216","volume":"3","author":"P Wales","year":"2013","unstructured":"Wales P, Pinho R, L\u00e1zaro DF, Outeiro TF. Limelight on alpha-synuclein: pathological and mechanistic implications in neurodegeneration. J Parkinsons Dis. 2013;3:415\u201359. doi: 10.3233\/JPD-130216 .","journal-title":"J Parkinsons Dis"},{"key":"310_CR67","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.neuron.2005.01.010","volume":"45","author":"BC Wittmann","year":"2005","unstructured":"Wittmann BC, Schott BH, Guderian S, Frey JU, Heinze H-J, D\u00fczel E. Reward-related FMRI activation of dopaminergic midbrain is associated with enhanced hippocampus-dependent long-term memory formation. Neuron. 2005;45:459\u201367. doi: 10.1016\/j.neuron.2005.01.010 .","journal-title":"Neuron"},{"key":"310_CR68","doi-asserted-by":"crossref","first-page":"e0119928","DOI":"10.1371\/journal.pone.0119928","volume":"10","author":"S Zhang","year":"2015","unstructured":"Zhang S, Xiao Q, Le W. Olfactory dysfunction and neurotransmitter disturbance in olfactory bulb of transgenic mice expressing human A53T mutant \u03b1-synuclein. PLoS One. 2015;10:e0119928. doi: 10.1371\/journal.pone.0119928 .","journal-title":"PLoS One"},{"key":"310_CR69","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1126\/science.1090154","volume":"302","author":"Y Zhou","year":"2003","unstructured":"Zhou Y, Su Y, Li B, Liu F, Ryder JW, Wu X, et al. Nonsteroidal anti-inflammatory drugs can lower amyloidogenic Abeta42 by inhibiting Rho. Science. 2003;302:1215\u20137. doi: 10.1126\/science.1090154 .","journal-title":"Science"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-016-0310-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T22:25:14Z","timestamp":1718490314000},"score":1,"resource":{"primary":{"URL":"http:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-016-0310-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,22]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["310"],"URL":"https:\/\/doi.org\/10.1186\/s40478-016-0310-y","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,22]]},"article-number":"39"}}